Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : hematology

Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China

Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China
03/23/2026 | Companies
Belief BioMed (“BBM”) and Grand Life Sciences Group Co., Ltd. (“Grand Life Sciences”) have entered into an exclusive partnership agreement. As part of the deal, Belief BioMed will provide Grand Life Sciences with commercialization rights for its investigational therapy, BBM-H803, across Mainland...
BBM-H803, BBM-H901, Belief BioMed, biotech industry, biotechnology partnership, China healthcare, clinical development, commercialization rights, drug development, gene therapy, Grand Life Sciences, healthcare innovation, hematology, hemophilia A, hemophilia treatment, innovative therapies, medical research, pharmaceutical collaboration, rare diseases

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
GileadNews: In partnership with Kite Pharma, we are excited to share groundbreaking cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) conferences. Our contribution includes over 20 abstracts, featuring late-breaking findings in...
American Society of Clinical Oncology, ASCO, cancer research, cancer treatment, CAR T-cell therapy, clinical trials, collaborative research, EHA, European Hematology Association, GileadNews, hematology, innovative therapies, investigational therapy, Kite Pharma, metastatic triple-negative breast cancer, oncology, Phase 2 results, recurrent glioblastoma, refractory multiple myeloma, relapsed multiple myeloma


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com